Clinical Trials Directory

Trials / Completed

CompletedNCT06229444

Predict + Protect Study: Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to ILI

Predict + Protect: A Randomized Controlled Trial Exploring the Effectiveness of a Predictive Health Education Intervention on the Adoption of Protective Behaviors Related to Influenza-like Illness (ILI)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
17,043 (actual)
Sponsor
Evidation Health · Industry
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The goal of this prospective, digital randomized controlled trial is to evaluate the effectiveness of a predictive ILI detection algorithm and associated alerts during influenza season for adults living in the contigent United States. The main study objectives are to assess the effectiveness of predictive ILI detection algorithm and associated alerts on protective behaviors related to ILI and assess the accuracy of a predictive ILI detection algorithm using participant self-reported ILI symptoms and diagnosis.

Conditions

Interventions

TypeNameDescription
BEHAVIORALILI Predictive Alerts, Reactive Content, and Proactive ContentParticipants receive ILI-related education, feedback, and opportunities to self-monitor ILI symptoms, in addition they also receive alerts about potential ILI illness, and reactive and personalized content about protective health behaviors.
BEHAVIORALILI Predictive Alerts, Reactive ContentParticipants receive alerts about potential ILI illness, and reactive and personalized content about protective health behaviors.
BEHAVIORALProactive ContentParticipants receive ILI-related education, feedback, and opportunities to self-monitor ILI symptoms.
BEHAVIORALNo InterventionParticipants will not receive predictive alerts or reactive content after reporting symptoms or proactive IILI-related health educational content

Timeline

Start date
2024-02-12
Primary completion
2024-08-05
Completion
2024-09-06
First posted
2024-01-29
Last updated
2024-09-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06229444. Inclusion in this directory is not an endorsement.